Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Mesalamine Delayed Release Tablets vs Asacol in Ulcerative Colitis
NCT01045018Phase 3Completed
- Sponsor
- EMET Pharmaceuticals
- Start
- Jan 2008
- Primary completion
- Jun 2009
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of Salcrozine in ulcerative colitis (UC), sponsored by EMET Pharmaceuticals. Started Jan 2008; status: completed.
02
Drugs
Salcrozine
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT01045018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01045018.